“FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES”. ISIR Journal of Business and Management Studies (ISIRJBMS), vol. 3, no. 5, Oct. 2026, pp. 45-55, https://isirpublisher.com/index.php/isirjbms/article/view/48.